Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,020 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma

NCT01724177

Conditions: Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Nagoya City University Hospital Nagoya, Aichi-ken, Japan

National Cancer Center Hospital East Kashiwa, Chiba, Japan

Ehime University Hospital Tōon, Ehime, Japan

Iwate Medical University Hospital Morioka, Iwate, Japan

View all 18 locations

View Trial Details

Completed

Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT01804101

Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia

NCT01558167

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: University Hospital of Cologne Cologne, Germany

View Trial Details

Completed

Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

NCT00278213

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria

Hanuschkrankenhaus Vienna, Austria

Allgemeinen Krankenhaus Celle Kinderklinik Celle, Germany

St. Johannes Hospital - Medical Klinik II Duisburg, Germany

View all 19 locations

View Trial Details

Completed

Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT00274963

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Humaine - Clinic Bad Saarow, Germany

Schwerpunktpraxis fuer Haematologie und Internistische Onkologie Berlin, Germany

Praxis Fuer Haematologie Internistische Onkologie Cologne, Germany

Internistische Gemeinschaftspraxis - Halle Halle, Germany

View Trial Details

Completed

Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia

NCT00281892

Conditions: Anemia, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations: Hamatologische/Onkologische Gemeinschaftspraxis - Augsburg Augsburg, Germany

Onkologische Schwerpunktpraxis und Tagesklinik Dres Bad Soden, Germany

Internistische Gemeinschaftspraxis - Berlin Berlin, Germany

Charite - Campus Charite Mitte Berlin, Germany

View all 46 locations

View Trial Details

Completed

Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia

NCT00275015

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik Vienna, Austria

Hanuschkrankenhaus Vienna, Austria

Humaine - Clinic Bad Saarow, Germany

Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany

View all 53 locations

View Trial Details

Completed

Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT01191190

Conditions: CLL, Chronic Disease, Disease Attributes, +15 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

University of California San Diego, Moores Cancer Center La Jolla, California, United States

View Trial Details

Completed

Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline

NCT00794820

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

NCT00539695

Conditions: ALL, AML, Acute Lymphoblastic Leukemia, +31 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions